Masaki Shiota

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 107

Top Venues

International journal of urology : official journal of the Japanese Urological Association

Cancer science

Journal of immunology (Baltimore, Md. : 1950)

Annals of surgical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Tokiyoshi Tanegashima, Masaki Shiota, Nobuhiro Fujiyama, Shintaro Narita, Tomonori Habuchi, Genshiro Fukuchi, Dai Takamatsu, Yoshinao Oda, Hideaki Miyake, Masayuki Takahashi, Mototsugu Oya, Norihiko Tsuchiya, Naoya Masumori, Hideyasu Matsuyama, Wataru Obara, Nobuo Shinohara, Kiyohide Fujimoto, Masahiro Nozawa, Kojiro Ohba, Chikara Ohyama, Katsuyoshi Hashine, Shusuke Akamatsu, Tomomi Kamba, Koji Mita, Momokazu Gotoh, Shuichi Tatarano, Masato Fujisawa, Yoshihiko Tomita, Shoichiro Mukai, Keiichi Ito, Shoji Tokunaga, Masatoshi Eto
Effect of HLA Genotype on Anti-PD-1 Antibody Treatment for Advanced Renal Cell Carcinoma in the SNiP-RCC Study. Journal of immunology (Baltimore, Md. : 1950) 213 (1) (2024)
Satoshi Kobayashi, Keiji Tsukino, Jun Mutaguchi, Tokiyoshi Tanegashima, Shunsuke Goto, Takashi Matsumoto, Masaki Shiota, Masatoshi Eto
Functional outcomes in robot-assisted partial nephrectomy with three-dimensional images reconstructed from computed tomography: a propensity score-matched comparative analysis. Journal of robotic surgery 18 (1) (2024)
Masaki Shiota, Satoshi Endo, Shigehiro Tsukahara, Tokiyoshi Tanegashima, Satoshi Kobayashi, Takashi Matsumoto, Masatoshi Eto
Importance of 3β-hydroxysteroid dehydrogenases and their clinical use in prostate cancer. Endocrine-related cancer 31 (7) (2024)
Masashi Kato, Masaki Shiota, Takahiro Kimura, Ryoichi Hanazawa, Akihiro Hirakawa, Dai Takamatsu, Kojiro Tashiro, Yoshiyuki Matsui, Katsuyoshi Hashine, Ryoichi Saito, Akira Yokomizo, Yoshiyuki Yamamoto, Shintaro Narita, Kohei Hashimoto, Hiroaki Matsumoto, Shusuke Akamatsu, Naotaka Nishiyama, Masatoshi Eto, Hiroshi Kitamura, Toyonori Tsuzuki, null null
Validation study on the 2 mm diameter cutoff in lymph node-positive cases following radical prostatectomy in accordance with the AJCC/UICC TNM 8th edition: Real-world data analysis from a Japanese cohort. International journal of urology : official journal of the Japanese Urological Association 31 (6) (2024)
Masaki Shiota, Shohei Nagakawa, Shigehiro Tsukahara, Takashi Matsumoto, Tokiyoshi Tanegashima, Masatoshi Eto
Independent validation of genetic risk model to progression after intravesical bacillus Calmette-Guérin therapy for non-muscle invasive bladder cancer. International journal of urology : official journal of the Japanese Urological Association 31 (8) (2024)
Masaki Shiota, Dai Takamatsu, Yoshiyuki Matsui, Akira Yokomizo, Shuichi Morizane, Ryoichi Saito, Makito Miyake, Masakazu Tsutsumi, Yoshiyuki Yamamoto, Kojiro Tashiro, Ryotaro Tomida, Shintaro Narita, Kohei Edamura, Takahiro Yamaguchi, Kohei Hashimoto, Masashi Kato, Takashi Kasahara, Takayuki Yoshino, Shusuke Akamatsu, Tomoyuki Kaneko, Akihiro Matsukawa, Ryuji Matsumoto, Akira Joraku, Toshihiro Saito, Takuma Kato, Manabu Kato, Hideki Enokida, Shinichi Sakamoto, Naoki Terada, Hidenori Kanno, Naotaka Nishiyama, Takahiro Kimura, Hiroshi Kitamura, Masatoshi Eto, null null
Prognostication in Lymph Node-Positive Prostate Cancer with No PSA Persistence After Radical Prostatectomy. Annals of surgical oncology 31 (6) (2024)
Masaki Shiota, Takahiro Kimura, Naotaka Nishiyama, Hiroshi Kitamura, Masatoshi Eto, null null
ASO Author Reflections: Treatment Choice for Lymph Node-Positive Prostate Cancer with No PSA Persistence After Radical Prostatectomy. Annals of surgical oncology 31 (6) (2024)
Leandro Blas, Masaki Shiota, Tokiyoshi Tanegashima, Satoshi Kobayashi, Takashi Matsumoto, Masatoshi Eto
Survival beyond cabazitaxel for metastatic castration-resistant prostate cancer. International journal of urology : official journal of the Japanese Urological Association (2024)
Shohei Nagakawa, Masaki Shiota, Dai Takamatsu, Shigehiro Tsukahara, Takashi Mastumoto, Leandro Blas, Junichi Inokuchi, Yoshihiro Oda, Masatoshi Eto
Clinical features and oncological outcomes of bladder cancer microsatellite instability. International journal of urology : official journal of the Japanese Urological Association (2024)
Masaki Shiota, Satoshi Endo, Shigehiro Tsukahara, Tokiyoshi Tanegashima, Satoshi Kobayashi, Takashi Matsumoto, Masatoshi Eto
Importance of 3β-hydroxysteroid dehydrogenases and their clinical use in prostate cancer. Endocrine-related cancer 31 (7) (2024)
Tokiyoshi Tanegashima, Masaki Shiota, Nobuhiro Fujiyama, Shintaro Narita, Tomonori Habuchi, Genshiro Fukuchi, Dai Takamatsu, Yoshinao Oda, Hideaki Miyake, Masayuki Takahashi, Mototsugu Oya, Norihiko Tsuchiya, Naoya Masumori, Hideyasu Matsuyama, Wataru Obara, Nobuo Shinohara, Kiyohide Fujimoto, Masahiro Nozawa, Kojiro Ohba, Chikara Ohyama, Katsuyoshi Hashine, Shusuke Akamatsu, Tomomi Kamba, Koji Mita, Momokazu Gotoh, Shuichi Tatarano, Masato Fujisawa, Yoshihiko Tomita, Shoichiro Mukai, Keiichi Ito, Shoji Tokunaga, Masatoshi Eto
Effect of HLA Genotype on Anti-PD-1 Antibody Treatment for Advanced Renal Cell Carcinoma in the SNiP-RCC Study. Journal of immunology (Baltimore, Md. : 1950) 213 (1) (2024)
Shohei Nagakawa, Masaki Shiota, Dai Takamatsu, Shigehiro Tsukahara, Takashi Mastumoto, Leandro Blas, Junichi Inokuchi, Yoshihiro Oda, Masatoshi Eto
Clinical features and oncological outcomes of bladder cancer microsatellite instability. International journal of urology : official journal of the Japanese Urological Association 31 (4) (2024)
Masashi Kato, Masaki Shiota, Takahiro Kimura, Ryoichi Hanazawa, Akihiro Hirakawa, Dai Takamatsu, Kojiro Tashiro, Yoshiyuki Matsui, Katsuyoshi Hashine, Ryoichi Saito, Akira Yokomizo, Yoshiyuki Yamamoto, Shintaro Narita, Kohei Hashimoto, Hiroaki Matsumoto, Shusuke Akamatsu, Naotaka Nishiyama, Masatoshi Eto, Hiroshi Kitamura, Toyonori Tsuzuki, null null
Validation study on the 2 mm diameter cutoff in lymph node-positive cases following radical prostatectomy in accordance with the AJCC/UICC TNM 8th edition: Real-world data analysis from a Japanese cohort. International journal of urology : official journal of the Japanese Urological Association 31 (6) (2024)
Masaki Shiota, Takahiro Kimura, Naotaka Nishiyama, Hiroshi Kitamura, Masatoshi Eto, null null
ASO Author Reflections: Treatment Choice for Lymph Node-Positive Prostate Cancer with No PSA Persistence After Radical Prostatectomy. Annals of surgical oncology 31 (6) (2024)
Tokiyoshi Tanegashima, Masaki Shiota, Takahiro Kimura, Dai Takamatsu, Yoshiyuki Matsui, Akira Yokomizo, Ryoichi Saito, Shuichi Morizane, Makito Miyake, Masakazu Tsutsumi, Yoshiyuki Yamamoto, Kojiro Tashiro, Ryotaro Tomida, Kohei Edamura, Shintaro Narita, Takahiro Yamaguchi, Takashi Kasahara, Kohei Hashimoto, Masashi Kato, Takayuki Yoshino, Shusuke Akamatsu, Akihiro Matsukawa, Tomoyuki Kaneko, Ryuji Matsumoto, Akira Joraku, Manabu Kato, Toshihiro Saito, Takuma Kato, Shuichi Tatarano, Shinichi Sakamoto, Hidenori Kanno, Naoki Terada, Naotaka Nishiyama, Hiroshi Kitamura, Masatoshi Eto, null null
Prognosis based on postoperative PSA levels and treatment in prostate cancer with lymph node involvement. International journal of clinical oncology (2024)
Shohei Nagakawa, Masaki Shiota, Dai Takamatsu, Shigehiro Tsukahara, Takashi Mastumoto, Leandro Blas, Junichi Inokuchi, Yoshihiro Oda, Masatoshi Eto
Clinical features and oncological outcomes of bladder cancer microsatellite instability. International journal of urology : official journal of the Japanese Urological Association 31 (4) (2024)
Masaki Shiota, Tokiyoshi Tanegashima, Shuichi Tatarano, Toshiyuki Kamoto, Hideyasu Matsuyama, Hideki Sakai, Tsukasa Igawa, Tomomi Kamba, Naohiro Fujimoto, Akira Yokomizo, Seiji Naito, Masatoshi Eto
The effect of human leukocyte antigen genotype on survival in advanced prostate cancer treated with primary androgen deprivation therapy: the KYUCOG-1401-A study. Prostate cancer and prostatic diseases (2024)
Masaki Shiota, Shohei Nagakawa, Shigehiro Tsukahara, Takashi Matsumoto, Tokiyoshi Tanegashima, Masatoshi Eto
Independent validation of genetic risk model to progression after intravesical bacillus Calmette-Guérin therapy for non-muscle invasive bladder cancer. International journal of urology : official journal of the Japanese Urological Association 31 (8) (2024)
Masashi Kato, Masaki Shiota, Takahiro Kimura, Ryoichi Hanazawa, Akihiro Hirakawa, Dai Takamatsu, Kojiro Tashiro, Yoshiyuki Matsui, Katsuyoshi Hashine, Ryoichi Saito, Akira Yokomizo, Yoshiyuki Yamamoto, Shintaro Narita, Kohei Hashimoto, Hiroaki Matsumoto, Shusuke Akamatsu, Naotaka Nishiyama, Masatoshi Eto, Hiroshi Kitamura, Toyonori Tsuzuki, null null
Validation study on the 2 mm diameter cutoff in lymph node-positive cases following radical prostatectomy in accordance with the AJCC/UICC TNM 8th edition: Real-world data analysis from a Japanese cohort. International journal of urology : official journal of the Japanese Urological Association (2024)
Tokiyoshi Tanegashima, Masaki Shiota, Nobuhiro Fujiyama, Shintaro Narita, Tomonori Habuchi, Genshiro Fukuchi, Dai Takamatsu, Yoshinao Oda, Hideaki Miyake, Masayuki Takahashi, Mototsugu Oya, Norihiko Tsuchiya, Naoya Masumori, Hideyasu Matsuyama, Wataru Obara, Nobuo Shinohara, Kiyohide Fujimoto, Masahiro Nozawa, Kojiro Ohba, Chikara Ohyama, Katsuyoshi Hashine, Shusuke Akamatsu, Tomomi Kamba, Koji Mita, Momokazu Gotoh, Shuichi Tatarano, Masato Fujisawa, Yoshihiko Tomita, Shoichiro Mukai, Keiichi Ito, Shoji Tokunaga, Masatoshi Eto
Effect of HLA Genotype on Anti-PD-1 Antibody Treatment for Advanced Renal Cell Carcinoma in the SNiP-RCC Study. Journal of immunology (Baltimore, Md. : 1950) 213 (1) (2024)
Masaki Shiota, Dai Takamatsu, Yoshiyuki Matsui, Akira Yokomizo, Shuichi Morizane, Ryoichi Saito, Makito Miyake, Masakazu Tsutsumi, Yoshiyuki Yamamoto, Kojiro Tashiro, Ryotaro Tomida, Shintaro Narita, Kohei Edamura, Takahiro Yamaguchi, Kohei Hashimoto, Masashi Kato, Takashi Kasahara, Takayuki Yoshino, Shusuke Akamatsu, Tomoyuki Kaneko, Akihiro Matsukawa, Ryuji Matsumoto, Akira Joraku, Toshihiro Saito, Takuma Kato, Manabu Kato, Hideki Enokida, Shinichi Sakamoto, Naoki Terada, Hidenori Kanno, Naotaka Nishiyama, Takahiro Kimura, Hiroshi Kitamura, Masatoshi Eto, null null
Prognostication in Lymph Node-Positive Prostate Cancer with No PSA Persistence After Radical Prostatectomy. Annals of surgical oncology 31 (6) (2024)
Tokiyoshi Tanegashima, Masaki Shiota, Masatoshi Eto
Reply to Letter to the Editor on "Impact of proton pump inhibitors on the efficacy of androgen receptor signaling inhibitors in metastatic castration-resistant prostate cancer patients". The Prostate (2024)
Taketo Kawai, Mizuki Onozawa, Satoru Taguchi, Masaki Shiota, Shinichi Sakamoto, Yoshiyuki Yamamoto, Yasuhide Kitagawa, Tohru Nakagawa, Shiro Hinotsu, Haruki Kume, null null
Changes in the trends of initial treatment for newly diagnosed prostate cancer in Japan: a nationwide multi-institutional study. Japanese journal of clinical oncology (2024)
Tokiyoshi Tanegashima, Masaki Shiota, Nobuhiro Fujiyama, Shintaro Narita, Tomonori Habuchi, Genshiro Fukuchi, Dai Takamatsu, Yoshinao Oda, Hideaki Miyake, Masayuki Takahashi, Mototsugu Oya, Norihiko Tsuchiya, Naoya Masumori, Hideyasu Matsuyama, Wataru Obara, Nobuo Shinohara, Kiyohide Fujimoto, Masahiro Nozawa, Kojiro Ohba, Chikara Ohyama, Katsuyoshi Hashine, Shusuke Akamatsu, Tomomi Kamba, Koji Mita, Momokazu Gotoh, Shuichi Tatarano, Masato Fujisawa, Yoshihiko Tomita, Shoichiro Mukai, Keiichi Ito, Shoji Tokunaga, Masatoshi Eto
Effect of HLA Genotype on Anti-PD-1 Antibody Treatment for Advanced Renal Cell Carcinoma in the SNiP-RCC Study. Journal of immunology (Baltimore, Md. : 1950) (2024)
Masaki Shiota, Shohei Nagakawa, Shigehiro Tsukahara, Takashi Matsumoto, Tokiyoshi Tanegashima, Masatoshi Eto
Independent validation of genetic risk model to progression after intravesical bacillus Calmette-Guérin therapy for non-muscle invasive bladder cancer. International journal of urology : official journal of the Japanese Urological Association (2024)
Masaki Shiota, Takahiro Kimura, Naotaka Nishiyama, Hiroshi Kitamura, Masatoshi Eto, null null
ASO Author Reflections: Treatment Choice for Lymph Node-Positive Prostate Cancer with No PSA Persistence After Radical Prostatectomy. Annals of surgical oncology (2024)
Tokiyoshi Tanegashima, Masaki Shiota, Nobuhiro Fujiyama, Shintaro Narita, Tomonori Habuchi, Genshiro Fukuchi, Dai Takamatsu, Yoshinao Oda, Hideaki Miyake, Masayuki Takahashi, Mototsugu Oya, Norihiko Tsuchiya, Naoya Masumori, Hideyasu Matsuyama, Wataru Obara, Nobuo Shinohara, Kiyohide Fujimoto, Masahiro Nozawa, Kojiro Ohba, Chikara Ohyama, Katsuyoshi Hashine, Shusuke Akamatsu, Tomomi Kamba, Koji Mita, Momokazu Gotoh, Shuichi Tatarano, Masato Fujisawa, Yoshihiko Tomita, Shoichiro Mukai, Keiichi Ito, Shoji Tokunaga, Masatoshi Eto
Effect of HLA Genotype on Anti-PD-1 Antibody Treatment for Advanced Renal Cell Carcinoma in the SNiP-RCC Study. Journal of immunology (Baltimore, Md. : 1950) 213 (1) (2024)
Tokiyoshi Tanegashima, Masaki Shiota, Shigehiro Tsukahara, Jun Mutaguch, Shunsuke Goto, Satoshi Kobayashi, Takashi Matsumoto, Masatoshi Eto
Impact of proton pump inhibitors on the efficacy of androgen receptor signaling inhibitors in metastatic castration-resistant prostate cancer patients. The Prostate (2024)
Masaki Shiota, Satoshi Endo, Shigehiro Tsukahara, Tokiyoshi Tanegashima, Satoshi Kobayashi, Takashi Matsumoto, Masatoshi Eto
Importance of 3β-hydroxysteroid dehydrogenases and their clinical use in prostate cancer. Endocrine-related cancer 31 (7) (2024)
Masaki Shiota, Dai Takamatsu, Yoshiyuki Matsui, Akira Yokomizo, Shuichi Morizane, Ryoichi Saito, Makito Miyake, Masakazu Tsutsumi, Yoshiyuki Yamamoto, Kojiro Tashiro, Ryotaro Tomida, Shintaro Narita, Kohei Edamura, Takahiro Yamaguchi, Kohei Hashimoto, Masashi Kato, Takashi Kasahara, Takayuki Yoshino, Shusuke Akamatsu, Tomoyuki Kaneko, Akihiro Matsukawa, Ryuji Matsumoto, Akira Joraku, Toshihiro Saito, Takuma Kato, Manabu Kato, Hideki Enokida, Shinichi Sakamoto, Naoki Terada, Hidenori Kanno, Naotaka Nishiyama, Takahiro Kimura, Hiroshi Kitamura, Masatoshi Eto, null null
Prognostication in Lymph Node-Positive Prostate Cancer with No PSA Persistence After Radical Prostatectomy. Annals of surgical oncology (2024)
Tokiyoshi Tanegashima, Masaki Shiota, Nobuhiro Fujiyama, Shintaro Narita, Tomonori Habuchi, Genshiro Fukuchi, Dai Takamatsu, Yoshinao Oda, Hideaki Miyake, Masayuki Takahashi, Mototsugu Oya, Norihiko Tsuchiya, Naoya Masumori, Hideyasu Matsuyama, Wataru Obara, Nobuo Shinohara, Kiyohide Fujimoto, Masahiro Nozawa, Kojiro Ohba, Chikara Ohyama, Katsuyoshi Hashine, Shusuke Akamatsu, Tomomi Kamba, Koji Mita, Momokazu Gotoh, Shuichi Tatarano, Masato Fujisawa, Yoshihiko Tomita, Shoichiro Mukai, Keiichi Ito, Shoji Tokunaga, Masatoshi Eto
Effect of HLA Genotype on Anti-PD-1 Antibody Treatment for Advanced Renal Cell Carcinoma in the SNiP-RCC Study. Journal of immunology (Baltimore, Md. : 1950) 213 (1) (2024)
Tokiyoshi Tanegashima, Masaki Shiota, Nobuhiro Fujiyama, Shintaro Narita, Tomonori Habuchi, Genshiro Fukuchi, Dai Takamatsu, Yoshinao Oda, Hideaki Miyake, Masayuki Takahashi, Mototsugu Oya, Norihiko Tsuchiya, Naoya Masumori, Hideyasu Matsuyama, Wataru Obara, Nobuo Shinohara, Kiyohide Fujimoto, Masahiro Nozawa, Kojiro Ohba, Chikara Ohyama, Katsuyoshi Hashine, Shusuke Akamatsu, Tomomi Kamba, Koji Mita, Momokazu Gotoh, Shuichi Tatarano, Masato Fujisawa, Yoshihiko Tomita, Shoichiro Mukai, Keiichi Ito, Shoji Tokunaga, Masatoshi Eto
Effect of HLA Genotype on Anti-PD-1 Antibody Treatment for Advanced Renal Cell Carcinoma in the SNiP-RCC Study. Journal of immunology (Baltimore, Md. : 1950) 213 (1) (2024)
Leandro Blas, Masaki Shiota, Tokiyoshi Tanegashima, Satoshi Kobayashi, Takashi Matsumoto, Masatoshi Eto
Survival beyond cabazitaxel for metastatic castration-resistant prostate cancer. International journal of urology : official journal of the Japanese Urological Association 31 (7) (2024)
Tokiyoshi Tanegashima, Masaki Shiota, Shigehiro Tsukahara, Jun Mutaguch, Shunsuke Goto, Satoshi Kobayashi, Takashi Matsumoto, Masatoshi Eto
Impact of proton pump inhibitors on the efficacy of androgen receptor signaling inhibitors in metastatic castration-resistant prostate cancer patients. The Prostate 84 (14) (2024)
Leandro Blas, Masaki Shiota, Shigehiro Tsukahara, Shohei Nagakawa, Takashi Matsumoto, Masatoshi Eto
Adverse Events of Abiraterone Acetate Versus Enzalutamide. Urology practice (2023)
Leandro Blas, Masaki Shiota, Tokiyoshi Tanegashima, Shigehiro Tsukahara, Shohei Ueda, Jun Mutaguchi, Shunsuke Goto, Satoshi Kobayashi, Takashi Matsumoto, Junichi Inokuchi, Masatoshi Eto
Validation of schedules for optimal prostate-specific antigen monitoring after radical prostatectomy. International journal of urology : official journal of the Japanese Urological Association 31 (4) (2023)
Masaki Shiota, Shusuke Akamatsu, Yuya Sekine, Hiroko Kimura, Shintaro Narita, Naohiro Fujimoto, Naoki Terada, Leandro Blas, Tomonori Habuchi, Toshiyuki Kamoto, Yukihide Momozawa, Masatoshi Eto
Genetic variations predicting progression with docetaxel and novel androgen-receptor pathway inhibitors. Cancer science (2023)
Leandro Blas, Masaki Shiota, Tokiyoshi Tanegashima, Shigehiro Tsukahara, Shohei Ueda, Jun Mutaguchi, Shunsuke Goto, Satoshi Kobayashi, Takashi Matsumoto, Junichi Inokuchi, Masatoshi Eto
Validation of schedules for optimal prostate-specific antigen monitoring after radical prostatectomy. International journal of urology : official journal of the Japanese Urological Association 31 (4) (2023)
Leandro Blas, Masaki Shiota, Hideaki Miyake, Masayuki Takahashi, Mototsugu Oya, Norihiko Tsuchiya, Naoya Masumori, Hideyasu Matsuyama, Wataru Obara, Nobuo Shinohara, Kiyohide Fujimoto, Masahiro Nozawa, Kojiro Ohba, Chikara Ohyama, Katsuyoshi Hashine, Shusuke Akamatsu, Tomomi Kamba, Koji Mita, Momokazu Gotoh, Shuichi Tatarano, Masato Fujisawa, Yoshihiko Tomita, Shoichiro Mukai, Keiichi Ito, Tokiyoshi Tanegashima, Shoji Tokunaga, Masatoshi Eto, null null
Clinical factors for tumor response, progression, and survival in nivolumab for advanced renal cell carcinoma in the SNiP-RCC study. International journal of urology : official journal of the Japanese Urological Association (2023)
Leandro Blas, Masaki Shiota, Tokiyoshi Tanegashima, Shigehiro Tsukahara, Shohei Ueda, Jun Mutaguchi, Shunsuke Goto, Satoshi Kobayashi, Takashi Matsumoto, Junichi Inokuchi, Masatoshi Eto
Validation of schedules for optimal prostate-specific antigen monitoring after radical prostatectomy. International journal of urology : official journal of the Japanese Urological Association 31 (4) (2023)
Leandro Blas, Masaki Shiota, Takashi Matsumoto, Yoshifumi Hori, Motonobu Nakamura, Narihito Seki, Kentaro Kuroiwa, Akira Yokomizo, Futoshi Morokuma, Keijiro Kiyoshima, Masatoshi Eto
Bone-modifying agents are protective for symptomatic skeletal events in Radium-223 treatment. International journal of urology : official journal of the Japanese Urological Association (2023)
Akira Yokomizo, Masaki Shiota, Futoshi Morokuma, Masatoshi Eto, Hideyasu Matsuyama, Hiroaki Matsumoto, Toshiyuki Kamoto, Naoki Terada, Kazuya Kawahara, Hideki Enokida, Shuichi Tatarano, Naohiro Fujimoto, Katsuyoshi Higasijima, Hideki Sakai, Tomoaki Hakariya, Tsukasa Igawa, Shigetaka Suekane, Tomomi Kamba, Yutaka Sugiyama, Junji Kishimoto, Seiji Naito
GnRH antagonist monotherapy versus a GnRH agonist plus bicalutamide for advanced hormone-sensitive prostate cancer; KYUCOG-1401. International journal of urology : official journal of the Japanese Urological Association 31 (4) (2023)
Leandro Blas, Masaki Shiota, Tokiyoshi Tanegashima, Shigehiro Tsukahara, Shohei Ueda, Jun Mutaguchi, Shunsuke Goto, Satoshi Kobayashi, Takashi Matsumoto, Junichi Inokuchi, Masatoshi Eto
Validation of schedules for optimal prostate-specific antigen monitoring after radical prostatectomy. International journal of urology : official journal of the Japanese Urological Association (2023)
Masaki Shiota, Shusuke Akamatsu, Yuya Sekine, Hiroko Kimura, Shintaro Narita, Naohiro Fujimoto, Naoki Terada, Leandro Blas, Tomonori Habuchi, Toshiyuki Kamoto, Yukihide Momozawa, Masatoshi Eto
Genetic variations predicting progression with docetaxel and novel androgen-receptor pathway inhibitors. Cancer science (2023)
Leandro Blas, Masaki Shiota, Shigehiro Tsukahara, Shohei Nagakawa, Takashi Matsumoto, Masatoshi Eto
Adverse Events of Abiraterone Acetate vs Enzalutamide. Urology practice (2023)
Masaki Shiota, Naoki Terada, Takahiro Kimura, Hiroshi Kitamura, Toshiyuki Kamoto, Masatoshi Eto, null null
Differential cancer-specific survival with curative radiotherapy to the prostate for metastatic prostate cancer according to estimated survival by risk group. International journal of urology : official journal of the Japanese Urological Association (2023)
Masashi Kaitsumaru, Masaki Shiota, Dai Takamatsu, Leandro Blas, Takashi Matsumoto, Junichi Inokuchi, Yoshinao Oda, Masatoshi Eto
Interstitial pneumonia after regression by olaparib for neuroendocrine prostate cancer with BRCA1 mutation: a case report. International cancer conference journal 12 (2) (2023)
Masashi Kaitsumaru, Masaki Shiota, Dai Takamatsu, Leandro Blas, Takashi Matsumoto, Junichi Inokuchi, Yoshinao Oda, Masatoshi Eto
Interstitial pneumonia after regression by olaparib for neuroendocrine prostate cancer with BRCA1 mutation: a case report. International cancer conference journal 12 (2) (2023)
Leandro Blas, Masaki Shiota, Shigehiro Tsukahara, Shunsuke Goto, Fumio Kinoshita, Takashi Matsumoto, Keisuke Monji, Eiji Kashiwagi, Junichi Inokuchi, Masatoshi Eto
Fusion-targeted biopsy significantly improves prostate cancer detection in biopsy-naïve men. International journal of urology : official journal of the Japanese Urological Association (2023)
Akira Yokomizo, Masaki Shiota, Futoshi Morokuma, Masatoshi Eto, Hideyasu Matsuyama, Hiroaki Matsumoto, Toshiyuki Kamoto, Naoki Terada, Kazuya Kawahara, Hideki Enokida, Shuichi Tatarano, Naohiro Fujimoto, Katsuyoshi Higasijima, Hideki Sakai, Tomoaki Hakariya, Tsukasa Igawa, Shigetaka Suekane, Tomomi Kamba, Yutaka Sugiyama, Junji Kishimoto, Seiji Naito
GnRH antagonist monotherapy versus a GnRH agonist plus bicalutamide for advanced hormone-sensitive prostate cancer; KYUCOG-1401. International journal of urology : official journal of the Japanese Urological Association (2023)
Akira Yokomizo, Masaki Shiota, Futoshi Morokuma, Masatoshi Eto, Hideyasu Matsuyama, Hiroaki Matsumoto, Toshiyuki Kamoto, Naoki Terada, Kazuya Kawahara, Hideki Enokida, Shuichi Tatarano, Naohiro Fujimoto, Katsuyoshi Higasijima, Hideki Sakai, Tomoaki Hakariya, Tsukasa Igawa, Shigetaka Suekane, Tomomi Kamba, Yutaka Sugiyama, Junji Kishimoto, Seiji Naito
GnRH antagonist monotherapy versus a GnRH agonist plus bicalutamide for advanced hormone-sensitive prostate cancer; KYUCOG-1401. International journal of urology : official journal of the Japanese Urological Association 31 (4) (2023)
Ken Lee, Masaki Shiota, Dai Takamatsu, Miho Ushijima, Leandro Blas, Ayami Okabe, Shunichi Kajioka, Shunsuke Goto, Fumio Kinoshita, Takashi Matsumoto, Keisuke Monji, Eiji Kashiwagi, Junichi Inokuchi, Yoshinao Oda, Masatoshi Eto
Correlation between extended pelvic lymph node dissection and urinary incontinence at early phase after robot-assisted radical prostatectomy. International journal of urology : official journal of the Japanese Urological Association (2022)
Yoshiyuki Nagumo, Mizuki Onozawa, Takahiro Kojima, Naoki Terada, Masaki Shiota, Koji Mitsuzuka, Hiroaki Yasumoto, Hiroaki Matsumoto, Hideki Enokida, Takayuki Sugiyama, Kentaro Kuroiwa, Toshihiro Saito, Akira Yokomizo, Naoki Kohei, Ken-Ichi Tabata, Atsushi Takahashi, Mikio Sugimoto, Hiroshi Kitamura, Toshiyuki Kamoto, Hiroyuki Nishiyama, null null
Efficacy of combined androgen blockade therapy in patients with metastatic hormone-sensitive prostate cancer stratified by tumor burden. International journal of urology : official journal of the Japanese Urological Association 29 (5) (2022)
Kazuo Nishimura, Masaki Shiota, Masatoshi Eto, Takefumi Satoh, Angela Stroupe, Caroline Seo, Alyssa Uzumcu, Dianne Athene Ledesma
Conceptual assessment of HRQOL among Japanese non-metastatic castration-resistant prostate cancer (nmCRPC) patients. Cancer medicine (2022)
Leandro Blas, Masaki Shiota, Dai Takamatsu, Fumio Kinoshita, Takashi Matsumoto, Ken Lee, Keisuke Monji, Eiji Kashiwagi, Junichi Inokuchi, Masatoshi Eto
Novel nomogram to predict biochemical recurrence-free survival after radical prostatectomy. World journal of urology 41 (1) (2022)
Leandro Blas, Masaki Shiota, Masatoshi Eto
Active Surveillance in Intermediate-Risk Prostate Cancer: A Review of the Current Data. Cancers 14 (17) (2022)
Masaki Shiota
Editorial Comment to Effect of upfront combination therapy on the overall survival of patients with metastatic castration-sensitive prostate cancer: A multicenter retrospective study. International journal of urology : official journal of the Japanese Urological Association 29 (5) (2022)
Hiroki Komori, Leandro Blas, Masaki Shiota, Dai Takamatsu, Takashi Matsumoto, Ken Lee, Keisuke Monji, Eiji Kashiwagi, Junichi Inokuchi, Masatoshi Eto
Impact of nerve sparing in robot-assisted radical prostatectomy on the risk of positive surgical margin and biochemical recurrence. International journal of urology : official journal of the Japanese Urological Association 29 (8) (2022)
Masaki Shiota, Shusuke Akamatsu, Shigehiro Tsukahara, Shohei Nagakawa, Takashi Matsumoto, Masatoshi Eto
Androgen receptor mutations for precision medicine in prostate cancer. Endocrine-related cancer 29 (10) (2022)
Leandro Blas, Masaki Shiota, Dai Takamatsu, Fumio Kinoshita, Takashi Matsumoto, Ken Lee, Keisuke Monji, Eiji Kashiwagi, Junichi Inokuchi, Masatoshi Eto
Novel nomogram to predict biochemical recurrence-free survival after radical prostatectomy. World journal of urology 41 (1) (2022)
Leandro Blas, Masaki Shiota, Dai Takamatsu, Fumio Kinoshita, Takashi Matsumoto, Ken Lee, Keisuke Monji, Eiji Kashiwagi, Junichi Inokuchi, Masatoshi Eto
Novel nomogram to predict biochemical recurrence-free survival after radical prostatectomy. World journal of urology 41 (1) (2022)
Masaki Shiota, Ryo Inoue, Kojiro Tashiro, Keita Kobayashi, Shizuyo Horiyama, Hiromi Kanji, Masatoshi Eto, Shin Egawa, Jun Haginaka, Hideyasu Matsuyama
A Phase Ii Trial of Abiraterone With Dutasteride for Second-Generation Antiandrogen- And Chemotherapy-Naïve Patients With Castration-Resistant Prostate Cancer. Journal of clinical pharmacology (2022)
Leandro Blas, Masaki Shiota, Shohei Nagakawa, Shigehiro Tsukahara, Takashi Matsumoto, Keisuke Monji, Eiji Kashiwagi, Ario Takeuchi, Junichi Inokuchi, Masatoshi Eto
Validation of models predicting lymph node involvement probability in patients with prostate cancer. International journal of urology : official journal of the Japanese Urological Association 29 (5) (2022)
Eiji Kashiwagi, Masaki Shiota, Hidekazu Naganuma, Keisuke Monji, Kenjiro Imada, Ken Lee, Takashi Matsumoto, Ario Takeuchi, Junichi Inokuchi, Masatoshi Eto
Testosterone level in seminal vesicle fluid is a better indicator of erectile function than serum testosterone in patients with prostate cancer. International journal of urology : official journal of the Japanese Urological Association 29 (10) (2022)
Yudai Kudo, Satoshi Endo, Masatoshi Tanio, Tomofumi Saka, Rin Himura, Naohito Abe, Mitsumi Takeda, Eiji Yamaguchi, Yuta Yoshino, Yuki Arai, Hirohito Kashiwagi, Masayoshi Oyama, Akichika Itoh, Masaki Shiota, Naohiro Fujimoto, Akira Ikari
Antiandrogenic Effects of a Polyphenol in Carex kobomugi through Inhibition of Androgen Synthetic Pathway and Downregulation of Androgen Receptor in Prostate Cancer Cell Lines. International journal of molecular sciences 23 (22) (2022)
Takashi Matsumoto, Yoshifumi Hori, Masaki Shiota, Leandro Blas, Motonobu Nakamura, Narihito Seki, Kentaro Kuroiwa, Akira Yokomizo, Futoshi Morokuma, Keijiro Kiyoshima, Masatoshi Eto
Effectiveness and safety of radium-223 dichloride in patients with castration-resistant prostate cancer and bone metastases in real-world practice: A multi-institutional study. International journal of urology : official journal of the Japanese Urological Association (2022)
Ko Igami, Takeshi Uchiumi, Masaki Shiota, Saori Ueda, Shigehiro Tsukahara, Masaru Akimoto, Masatoshi Eto, Dongchon Kang
Extracellular vesicles expressing CEACAM proteins in the urine of bladder cancer patients. Cancer science 113 (9) (2022)
Masaki Shiota, Leandro Blas, Masatoshi Eto
Current Status and Future Perspective on the Management of Lymph Node-Positive Prostate Cancer after Radical Prostatectomy. Cancers 14 (11) (2022)
Miho Ushijima, Masaki Shiota, Takashi Matsumoto, Eiji Kashiwagi, Junichi Inokuchi, Masatoshi Eto
An oral first-in-class small molecule RSK inhibitor suppresses AR variants and tumor growth in prostate cancer. Cancer science 113 (5) (2022)
Masaki Shiota, Dai Takamatsu, Takahiro Kimura, Kojiro Tashiro, Yoshiyuki Matsui, Ryotaro Tomida, Ryoichi Saito, Masakazu Tsutsumi, Akira Yokomizo, Yoshiyuki Yamamoto, Kohei Edamura, Makito Miyake, Shuichi Morizane, Takayuki Yoshino, Akihiro Matsukawa, Shintaro Narita, Ryuji Matsumoto, Takashi Kasahara, Kohei Hashimoto, Hiroaki Matsumoto, Masashi Kato, Shusuke Akamatsu, Akira Joraku, Manabu Kato, Takahiro Yamaguchi, Toshihiro Saito, Tomoyuki Kaneko, Atsushi Takahashi, Takuma Kato, Shinichi Sakamoto, Enokida Hideki, Hidenori Kanno, Naoki Terada, Shigetaka Suekane, Naotaka Nishiyama, Masatoshi Eto, Hiroshi Kitamura, null null
Radiotherapy plus androgen deprivation therapy for prostate-specific antigen persistence in lymph node-positive prostate cancer. Cancer science 113 (7) (2022)
Masaki Shiota, Raf De Moor, Yosuke Koroki, David Bin-Chia Wu, David Bin-Chia Wu
Assessing the correlation between second progression-free survival (PFS2) and overall survival (OS) in advanced prostate cancer patients using medical data vision (MDV) claims database in Japan. Current medical research and opinion 38 (8) (2022)
Leandro Blas, Masaki Shiota, Dai Takamatsu, Fumio Kinoshita, Takashi Matsumoto, Ken Lee, Keisuke Monji, Eiji Kashiwagi, Junichi Inokuchi, Masatoshi Eto
Novel nomogram to predict biochemical recurrence-free survival after radical prostatectomy. World journal of urology (2022)
Takashi Matsumoto, Masaki Shiota, Leandro Blas, Masatoshi Eto
Role of Olaparib in the Management of Metastatic Castration-Resistant Prostate Cancer: A Japanese Clinician's Perspective. Cancer management and research 14 (2022)
Leandro Blas, Masaki Shiota
Unrecognized Pitfall When Doing Nerve-Sparing Surgery in Radical Prostatectomy. Annals of surgical oncology 28 (9) (2021)
Masaki Shiota, Naoki Terada, Toshihiro Saito, Akira Yokomizo, Naoki Kohei, Takayuki Goto, Sadafumi Kawamura, Yasuhiro Hashimoto, Atsushi Takahashi, Takahiro Kimura, Ken-Ichi Tabata, Ryotaro Tomida, Kohei Hashimoto, Toshihiko Sakurai, Toru Shimazui, Shinichi Sakamoto, Manabu Kamiyama, Nobumichi Tanaka, Koji Mitsuzuka, Takuma Kato, Shintaro Narita, Hiroaki Yasumoto, Shogo Teraoka, Masashi Kato, Takahiro Osawa, Yoshiyuki Nagumo, Hiroaki Matsumoto, Enokida Hideki, Takayuki Sugiyama, Kentaro Kuroiwa, Takahiro Inoue, Takashi Mizowaki, Toshiyuki Kamoto, Takahiro Kojima, Hiroshi Kitamura, Mikio Sugimoto, Hiroyuki Nishiyama, Masatoshi Eto, null null
Differential prognostic factors in low- and high-burden de novo metastatic hormone-sensitive prostate cancer patients. Cancer science 112 (4) (2021)
Takuya Yamashita, Masaki Shiota, Asako Machidori, Satoshi Kobayashi, Takashi Matsumoto, Keisuke Monji, Eiji Kashiwagi, Ario Takeuchi, Ryosuke Takahashi, Junichi Inokuchi, Ken-Ichiro Shiga, Akira Yokomizo, Masatoshi Eto
Efficacy and Safety of 4-Weekly Docetaxel for Castration-Resistant Prostate Cancer. Cancer investigation 39 (3) (2021)
Leandro Blas, Mizuki Onozawa, Masaki Shiota, Shiro Hinotsu, Shinichi Sakamoto, Yasuhide Kitagawa, Taketo Kawai, Masatoshi Eto, Haruki Kume, Hideyuki Akaza, null null
Long-term outcomes of androgen deprivation therapy in prostate cancer among Japanese men over 80 years old. Cancer science 112 (8) (2021)
Kei Mizuno, Takayuki Sumiyoshi, Takatsugu Okegawa, Naoki Terada, Satoshi Ishitoya, Yu Miyazaki, Takahiro Kojima, Hiromichi Katayama, Naohiro Fujimoto, Shingo Hatakeyama, Masaki Shiota, Koji Yoshimura, Yoshiyuki Matsui, Shintaro Narita, Hiroaki Matsumoto, Ryoma Kurahashi, Hidenori Kanno, Katsuhiro Ito, Hiroko Kimura, Yuki Kamiyama, Takuro Sunada, Takayuki Goto, Takashi Kobayashi, Hitoshi Yamada, Norihiko Tsuchiya, Tomomi Kamba, Hideyasu Matsuyama, Tomonori Habuchi, Masatoshi Eto, Chikara Ohyama, Akihiro Ito, Hiroyuki Nishiyama, Hiroshi Okuno, Toshiyuki Kamoto, Akihiro Fujimoto, Osamu Ogawa, Shusuke Akamatsu
Clinical Impact of Detecting Low-Frequency Variants in Cell-Free DNA on Treatment of Castration-Resistant Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (22) (2021)
Masaki Shiota, Shusuke Akamatsu, Shintaro Narita, Takayuki Sumiyoshi, Maki Fujiwara, Takeshi Uchiumi, Osamu Ogawa, Tomonori Habuchi, Masatoshi Eto
The association between missense polymorphisms in SRD5A2 and HSD3B1 and treatment failure with abiraterone for castration-resistant prostate cancer. The pharmacogenomics journal 21 (4) (2021)
Masaki Shiota, Naoki Terada, Hiroshi Kitamura, Takahiro Kojima, Toshihiro Saito, Akira Yokomizo, Naoki Kohei, Takayuki Goto, Sadafumi Kawamura, Yasuhiro Hashimoto, Atsushi Takahashi, Takahiro Kimura, Ken-Ichi Tabata, Ryotaro Tomida, Kohei Hashimoto, Toshihiko Sakurai, Toru Shimazui, Shinichi Sakamoto, Manabu Kamiyama, Nobumichi Tanaka, Koji Mitsuzuka, Takuma Kato, Shintaro Narita, Hiroaki Yasumoto, Shogo Teraoka, Masashi Kato, Takahiro Osawa, Yoshiyuki Nagumo, Hiroaki Matsumoto, Enokida Hideki, Takayuki Sugiyama, Kentaro Kuroiwa, Takahiro Inoue, Mikio Sugimoto, Takashi Mizowaki, Toshiyuki Kamoto, Hiroyuki Nishiyama, Masatoshi Eto, null null
Novel metastatic burden-stratified risk model in de novo metastatic hormone-sensitive prostate cancer. Cancer science 112 (9) (2021)
Takashi Babasaki, Kazuhiro Sentani, Yohei Sekino, Go Kobayashi, Quoc Thang Pham, Narutaka Katsuya, Shintaro Akabane, Daiki Taniyama, Tetsutaro Hayashi, Masaki Shiota, Naohide Oue, Jun Teishima, Akio Matsubara, Wataru Yasui
Overexpression of claspin promotes docetaxel resistance and is associated with prostate-specific antigen recurrence in prostate cancer. Cancer medicine 10 (16) (2021)
Mikifumi Koura, Masaki Shiota, Shohei Ueda, Takashi Matsumoto, Satoshi Kobayashi, Keisuke Monji, Eiji Kashiwagi, Ario Takeuchi, Junichi Inokuchi, Ken-Ichiro Shiga, Akira Yokomizo, Masatoshi Eto
Prognostic impact of prior local therapy in castration-resistant prostate cancer. Japanese journal of clinical oncology 51 (7) (2021)
Masaki Shiota, Ryota Sumikawa, Mizuki Onozawa, Shiro Hinotsu, Yasuhide Kitagawa, Shinichi Sakamoto, Taketo Kawai, Masatoshi Eto, Haruki Kume, Hideyuki Akaza, null null
Regional and facility disparities in androgen deprivation therapy for prostate cancer from a multi-institutional Japan-wide database. International journal of urology : official journal of the Japanese Urological Association 28 (5) (2021)
Masaki Shiota, Naohiro Fujimoto, Yohei Sekino, Shigehiro Tsukahara, Shohei Nagakawa, Dai Takamatsu, Tatsuro Abe, Fumio Kinoshita, Shohei Ueda, Miho Ushijima, Takashi Matsumoto, Eiji Kashiwagi, Junichi Inokuchi, Takeshi Uchiumi, Yoshinao Oda, Masatoshi Eto
Clinical impact of HSD3B1 polymorphism by metastatic volume and somatic HSD3B1 alterations in advanced prostate cancer. Andrologia (2021)
Satoshi Kobayashi, Masaki Shiota
Editorial Comment to Endoscopic laser treatment for urine leakage caused by an isolated calyx after robot-assisted partial nephrectomy. IJU case reports 4 (6) (2021)
Mizuki Kobayashi, Nobuhiro Fujiyama, Tokiyoshi Tanegashima, Shintaro Narita, Yoshiaki Yamamoto, Naohiro Fujimoto, Shohei Ueda, Ario Takeuchi, Kazuyuki Numakura, Tomonori Habuchi, Hideyasu Matsuyama, Masatoshi Eto, Masaki Shiota
Effect of HLA genotype on intravesical recurrence after bacillus Calmette-Guérin therapy for non-muscle-invasive bladder cancer. Cancer immunology, immunotherapy : CII (2021)
Takashi Matsumoto, Masaki Shiota
Editorial Comment to Prominent response to platinum-based chemotherapy in a patient with BRCA2 mutant-neuroendocrine prostate cancer and MDM2 amplification. IJU case reports 4 (4) (2021)
Sotaro Chikamatsu, Masaki Shiota, Mizuki Onozawa, Shiro Hinotsu, Yasuhide Kitagawa, Shinichi Sakamoto, Taketo Kawai, Masatoshi Eto, Haruki Kume, Hideyuki Akaza, null null
Dynamics of conditional survival and risk factors in androgen deprivation therapy for prostate cancer using a multi-institutional Japan-wide database. International journal of urology : official journal of the Japanese Urological Association 28 (9) (2021)
Hiroki Kobayashi, Satoshi Kobayashi, Masaki Shiota, Dai Takamatsu, Tatsuro Abe, Eiji Kashiwagi, Ario Takeuchi, Junichi Inokuchi, Kenichi Kohashi, Yoshiyuki Shioyama, Yoshinao Oda, Masatoshi Eto
Salvage robot-assisted radical prostatectomy after carbon ion radiotherapy: a case report. International cancer conference journal 10 (2) (2021)
Ario Takeuchi, Masaki Shiota
Editorial Comment to Resumption of anti-programmed cell death 1 monotherapy for severe immune-related adverse events experienced patient with renal cell carcinoma. IJU case reports 3 (5) (2020)
Naoki Terada, Takashi Mizowaki, Toshihiro Saito, Akira Yokomizo, Naoki Kohei, Ken-Ichi Tabata, Masaki Shiota, Atsushi Takahashi, Toru Shimazui, Takayuki Goto, Yasuhiro Hashimoto, Masato Fujii, Ryotaro Tomida, Toshihiko Sakurai, Kohei Hashimoto, Sadafumi Kawamura, Shogo Teraoka, Shinichi Sakamoto, Takahiro Kimura, Manabu Kamiyama, Shintaro Narita, Nobumichi Tanaka, Takuma Kato, Masashi Kato, Takahiro Osawa, Takahiro Kojima, Takahiro Inoue, Mikio Sugimoto, Hiroyuki Nishiyama, Toshiyuki Kamoto, null null
Potential effectiveness of local radiotherapy for extending survival and reducing symptomatic local events in patients with de novo metastatic prostate cancer. BJUI compass 1 (5) (2020)
Masaki Shiota, Naohiro Fujimoto, Yoshiaki Yamamoto, Ario Takeuchi, Katsunori Tatsugami, Takeshi Uchiumi, Hideyasu Matsuyama, Masatoshi Eto
Genome-wide association study of genetic variations associated with treatment failure after intravesical bacillus Calmette-Guérin therapy for non-muscle invasive bladder cancer. Cancer immunology, immunotherapy : CII 69 (7) (2020)
Masaki Shiota, Yohei Sekino, Shigehiro Tsukahara, Tatsuro Abe, Fumio Kinoshita, Kenjiro Imada, Shohei Ueda, Miho Ushijima, Shohei Nagakawa, Takashi Matsumoto, Eiji Kashiwagi, Ario Takeuchi, Junichi Inokuchi, Takeshi Uchiumi, Yoshinao Oda, Masatoshi Eto
Gene amplification of YB-1 in castration-resistant prostate cancer in association with aberrant androgen receptor expression. Cancer science 112 (1) (2020)
Momoe Itsumi, Masaki Shiota, Shunichi Kajioka, Masatoshi Eto
Profile of androgen receptor activators identified using high-throughput screen. Andrologia 53 (1) (2020)
Momoe Itsumi, Masaki Shiota, Yohei Sekino, Miho Ushijima, Eiji Kashiwagi, Ario Takeuchi, Junichi Inokuchi, Shunichi Kajioka, Takeshi Uchiumi, Masatoshi Eto
High-throughput screen identifies 5-HT receptor as a modulator of AR and a therapeutic target for prostate cancer. The Prostate 80 (11) (2020)
Masaki Shiota, Shintaro Narita, Tomonori Habuchi, Masatoshi Eto
Validated prognostic significance of YB-1 genetic variation in metastatic prostate cancer. The pharmacogenomics journal 21 (1) (2020)
Masaki Shiota, Naohiro Fujimoto, Eiji Kashiwagi, Masatoshi Eto
The Role of Nuclear Receptors in Prostate Cancer. Cells 8 (6) (2019)
Yohei Sekino, Xiangrui Han, Takafumi Kawaguchi, Takashi Babasaki, Keisuke Goto, Shogo Inoue, Tetsutaro Hayashi, Jun Teishima, Masaki Shiota, Wataru Yasui, Akio Matsubara
TUBB3 Reverses Resistance to Docetaxel and Cabazitaxel in Prostate Cancer. International journal of molecular sciences 20 (16) (2019)
Masaki Shiota, Miho Ushijima, Kenjiro Imada, Eiji Kashiwagi, Ario Takeuchi, Junichi Inokuchi, Katsunori Tatsugami, Shunichi Kajioka, Masatoshi Eto
Cigarette smoking augments androgen receptor activity and promotes resistance to antiandrogen therapy. The Prostate 79 (10) (2019)
Masaki Shiota, Motonobu Nakamura, Akira Yokomizo, Toshihisa Tomoda, Naotaka Sakamoto, Narihito Seki, Shuji Hasegawa, Takakazu Yunoki, Masahiko Harano, Kentaro Kuroiwa, Masatoshi Eto
Efficacy and safety of cabazitaxel for castration-resistant prostate cancer in patients with > 10 cycles of docetaxel chemotherapy: a multi-institutional study. Medical oncology (Northwood, London, England) 36 (4) (2019)

Masaki Shiota.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Masaki Shiota